Fig. 5: Peak viremia for DENV-2 live-attenuated vaccine virus and wild-type challenge virus. | npj Vaccines

Fig. 5: Peak viremia for DENV-2 live-attenuated vaccine virus and wild-type challenge virus.

From: Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques

Fig. 5

Shown are the peak viremia values from each animal following LAV vaccination or the following wild-type DENV-2 infection of unvaccinated control animals. Data are presented as log10-transformed genome equivalents (GE)/mL. Horizontal bars are the geometric means for each group. Data were analyzed by Welch’s ANOVA model and Dunnett’s T3 multiple comparisons test. *p < 0.05.

Back to article page